Respiratory failure in the elderly
Respiratory failure is not a disease, but a clinical syndrome caused by severe damage to lung function due to various reasons, leading to hypoxia or combined with carbon dioxide retention, which in turn leads to a series of physiological dysfunctions and metabolic disorders. At the same time, since respiratory failure has no obvious clinical features in the early stage, it is generally necessary to make a clear diagnosis through laboratory arterial blood gas analysis.
-
Site of disease:
Lungs and whole body -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Difficulty breathing convulsions proteinuria wheezing drowsiness -
Concurrent disease:
Related Drugs
Aminophylline Tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Salbutamol Sulfate Tablets
Indication: Used to relieve symptoms of bronchial asthma or asthmatic bronchitis accompanied by bronchospasm.
Manufacturer:
Tianjin Lisheng Pharmaceutical Co., Ltd.
Beclomethasone dipropionate aerosol
Indication: Treat and prevent bronchial asthma and allergic rhinitis.
Manufacturer:
Jewim Pharmaceutical (Shandong) Co., Ltd.
Doxapram Hydrochloride Injection
Indication: For respiratory failure.
Manufacturer:
YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
Terbutaline sulfate aerosol
Indication: Bronchial asthma, chronic asthmatic bronchitis, obstructive emphysema and other lung diseases associated with bronchospasm.
Terbutaline sulfate aerosol
Indication: Bronchial asthma, chronic asthmatic bronchitis, obstructive emphysema and other lung diseases accompanied by bronchospasm.
Salbutamol aerosol
Indication: Used to prevent and treat respiratory diseases such as bronchial asthma or asthmatic bronchitis accompanied by bronchospasm (stridor).
Manufacturer:
Beijing Haiderun Pharmaceutical Group Co., Ltd.
Terbutaline sulfate aerosol
Indication: Bronchial asthma, chronic asthmatic bronchitis, obstructive emphysema and other lung diseases associated with bronchospasm.